Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis (Q40396473)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2005

Language	Label	Description	Also known as
English	Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis	scientific article published on August 2005

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis (English)

1 reference

Europe PubMed Central

20 September 2017

Mycobacterium bovis

1 reference

based on heuristic

inferred from title

author name string

Karen E Logan

1

1 reference

Europe PubMed Central

20 September 2017

Mark A Chambers

2

1 reference

Europe PubMed Central

20 September 2017

R Glyn Hewinson

3

1 reference

Europe PubMed Central

20 September 2017

Philip J Hogarth

4

1 reference

Europe PubMed Central

20 September 2017

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

23

1 reference

Europe PubMed Central

20 September 2017

48-49

1 reference

Europe PubMed Central

20 September 2017

5526-5532

1 reference

Europe PubMed Central

20 September 2017

Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Tuberculosis vaccine development: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Immunology of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Jump-starting the immune system: prime-boosting comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

A selective oleic acid albumin agar medium for the cultivation ofMycobacterium bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Interleukin-17 family members and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Boosting vaccine for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.037

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.07.037

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40396473&oldid=2164975862"